Department of Molecular Therapeutics, The Scripps Research Institute-Scripps Florida, Jupiter, FL 33458, USA.
Neuropharmacology. 2011 Sep;61(4):687-98. doi: 10.1016/j.neuropharm.2011.05.012. Epub 2011 May 25.
Intravenous nicotine self-administration is the most direct measure of nicotine reinforcement in laboratory animals, but this procedure has proven difficult to establish in mice. We found that stable responding for nicotine in C57BL6/J mice was facilitated by prior instrumental training for food reward, initial exposure of mice to a lower unit dose of nicotine (0.03 mg kg(-1) per infusion) before access to higher doses, a slower rate of drug delivery (3-s versus 1-s infusion), consistency in schedule of daily testing, and low extraneous noise during testing. Under these conditions, we found that mice lever-pressed for nicotine (0.03-0.4 mg kg(-1) per infusion; 60-min test sessions) under a fixed-ratio 5 time-out 20-s (FR5TO20) reinforcement schedule and consumed the drug according to an inverted 'U'-shaped dose-response curve. Mice switched their responding onto a previously non-reinforced lever to continue earning nicotine infusions when the active/inactive lever assignment was reversed. The nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine decreased responding for nicotine, but not food rewards, verifying that nAChRs regulate nicotine self-administration in mice. The cue-light paired with nicotine delivery did not support responding when delivered independently of nicotine infusions, further verifying that mice responded selectivity for the drug. Nicotine-seeking responses extinguished when nicotine infusions and the cue-light were withheld, and exposure to the cue-light reinstated responding. Finally, mice without prior instrumental food training acquired stable responding for nicotine under the FR5TO20 schedule, but required a greater number of sessions. These data demonstrate that nicotine is an effective reinforcer in mice and establish conditions under which the drug is reliably self-administered by mice.
静脉内尼古丁自我给药是实验室动物中尼古丁强化作用的最直接测量方法,但在小鼠中已证明该程序难以建立。我们发现,通过先前的仪器训练获得食物奖励,在接触更高剂量之前先使小鼠接触较低的单位剂量尼古丁(0.03mg/kg 静脉内输注),降低药物输送速度(3 秒与 1 秒输注),每日测试计划的一致性以及测试过程中的低环境噪音,可以促进 C57BL6/J 小鼠对尼古丁的稳定反应。在这些条件下,我们发现小鼠在固定比率 5 超时 20 秒(FR5TO20)强化方案下通过 lever 按压(0.03-0.4mg/kg 静脉内输注;60 分钟测试期)摄取尼古丁,并根据倒置的“U”形剂量反应曲线消耗药物。当主动/非主动 lever 分配被反转时,小鼠将其反应切换到先前未被强化的 lever 上,以继续获得尼古丁输注。烟碱型乙酰胆碱受体(nAChR)拮抗剂美加仑胺降低了对尼古丁的反应,但不降低食物奖励,这证实了 nAChR 调节小鼠中的尼古丁自我给药。当单独给予与尼古丁输注无关时,与尼古丁输送配对的提示灯不会支持反应,这进一步验证了小鼠对药物的选择性反应。当停止给予尼古丁输注和提示灯时,尼古丁寻求反应会消失,并且暴露于提示灯会重新引发反应。最后,没有事先进行仪器训练的食物的小鼠在 FR5TO20 方案下获得了对尼古丁的稳定反应,但需要更多的测试。这些数据表明,尼古丁在小鼠中是一种有效的强化物,并建立了在这些条件下,小鼠可靠地自我给予药物的条件。